Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R L Wolfert

Showing results (21-30 of 35) with videos related to

Pageof 4
Sort By:
Urology|May 1, 1995
Molecular forms of prostate-specific antigen and the human kallikrein gene family: a new eraR T McCormack, H G Rittenhouse, J A Finlay, et al.
Annals of Clinical and Laboratory Science|May 1, 1995
Tau protein in cerebrospinal fluid as an aid in the diagnosis of Alzheimer's diseaseW A Munroe, P C Southwick, L Chang, et al.
Urology|December 31, 1997
A precursor form of PSA (pPSA) is a component of the free PSA in prostate cancer serumS D Mikolajczyk, L S Grauer, L S Millar, et al.
Hybridoma|January 8, 2000
Generation of PSA-ACT-specific monoclonal antibodies and their application in a sandwich immunoassayT J Wang, H J Linton, J Payne, et al.
Clinical Chemistry|June 3, 1999
Highly sensitive automated chemiluminometric assay for measuring free human glandular kallikrein-2G G Klee, M K Goodmanson, S J Jacobsen, et al.
Cancer Research|August 27, 1999
Identification of a novel complex between human kallikrein 2 and protease inhibitor-6 in prostate cancer tissueS D Mikolajczyk, L S Millar, K M Marker, et al.
Urology|June 1, 1997
Human glandular kallikrein 2 (hK2) expression in prostatic intraepithelial neoplasia and adenocarcinoma: a novel prostate cancer markerM F Darson, A Pacelli, P Roche, et al.
The Prostate. Supplement|January 1, 1996
Clearance rate of serum-free and total PSA following radical retropubic prostatectomyA W Partin, S Piantadosi, E N Subong, et al.
Urology|February 2, 2000
"BPSA," a specific molecular form of free prostate-specific antigen, is found predominantly in the transition zone of patients with nodular benign prostatic hyperplasiaS D Mikolajczyk, L S Millar, T J Wang, et al.
Urology|June 4, 1998
Development of monoclonal antibodies specific for human glandular kallikrein (hK2): development of a dual antibody immunoassay for hK2 with negligible prostate-specific antigen cross-reactivityJ A Finlay, C L Evans, J R Day, et al.
Pageof 4

Showing results (21-30 of 35) with videos related to

Sort By:
Pageof 4
Urology|May 1, 1995
Molecular forms of prostate-specific antigen and the human kallikrein gene family: a new eraR T McCormack, H G Rittenhouse, J A Finlay, et al.
Annals of Clinical and Laboratory Science|May 1, 1995
Tau protein in cerebrospinal fluid as an aid in the diagnosis of Alzheimer's diseaseW A Munroe, P C Southwick, L Chang, et al.
Urology|December 31, 1997
A precursor form of PSA (pPSA) is a component of the free PSA in prostate cancer serumS D Mikolajczyk, L S Grauer, L S Millar, et al.
Hybridoma|January 8, 2000
Generation of PSA-ACT-specific monoclonal antibodies and their application in a sandwich immunoassayT J Wang, H J Linton, J Payne, et al.
Clinical Chemistry|June 3, 1999
Highly sensitive automated chemiluminometric assay for measuring free human glandular kallikrein-2G G Klee, M K Goodmanson, S J Jacobsen, et al.
Cancer Research|August 27, 1999
Identification of a novel complex between human kallikrein 2 and protease inhibitor-6 in prostate cancer tissueS D Mikolajczyk, L S Millar, K M Marker, et al.
Urology|June 1, 1997
Human glandular kallikrein 2 (hK2) expression in prostatic intraepithelial neoplasia and adenocarcinoma: a novel prostate cancer markerM F Darson, A Pacelli, P Roche, et al.
The Prostate. Supplement|January 1, 1996
Clearance rate of serum-free and total PSA following radical retropubic prostatectomyA W Partin, S Piantadosi, E N Subong, et al.
Urology|February 2, 2000
"BPSA," a specific molecular form of free prostate-specific antigen, is found predominantly in the transition zone of patients with nodular benign prostatic hyperplasiaS D Mikolajczyk, L S Millar, T J Wang, et al.
Urology|June 4, 1998
Development of monoclonal antibodies specific for human glandular kallikrein (hK2): development of a dual antibody immunoassay for hK2 with negligible prostate-specific antigen cross-reactivityJ A Finlay, C L Evans, J R Day, et al.
Pageof 4